Abstract: Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods, systems and kits for determining the treatment modality of a cancer in a subject. The methods, systems and kits comprise expression-based analysis of biomarkers. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.

Abstract: A method for predicting the presence of melanoma comprises performing molecular profiling of at least one of genomic and transcriptomic material extracted from a skin swab sample collected from a lesion of a patient, extracting one or more biological features from the molecular profiling, comparing the one or more extracted biological features to one or more biological features corresponding to one or more reference skin swab samples collected from a plurality of reference patients, and predicting, based on the comparing, whether the lesion of the patient is cancerous.

Abstract: Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods, systems and kits for determining the treatment modality of a cancer in a subject. The methods, systems and kits comprise expression-based analysis of biomarkers. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.

Abstract: Disclosed herein, in certain instances, are methods for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods for determining the treatment modality of a cancer in a subject. The methods comprise expression-based analysis of non-coding targets and coding targets. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.

Abstract: A method for predicting the presence of melanoma comprises performing molecular profiling of at least one of genomic and transcriptomic material extracted from a skin swab sample collected from a lesion of a patient, extracting one or more biological features from the molecular profiling, comparing the one or more extracted biological features to one or more biological features corresponding to one or more reference skin swab samples collected from a plurality of reference patients, and predicting, based on the comparing, whether the lesion of the patient is cancerous.

Abstract: Disclosed herein, in certain instances, are methods for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods for determining the treatment modality of a cancer in a subject. The methods comprise expression-based analysis of non-coding targets and coding targets. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.

Abstract: Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods, systems and kits for determining the treatment modality of a cancer in a subject. The methods, systems and kits comprise expression-based analysis of biomarkers. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.